Advertisement
Friday, Oct 22, 2021
Outlook.com

The Red In That Green

Once known for strong patent laws, India is now yielding to pharma MNCs

The Red In That Green
The Red In That Green
outlookindia.com
2017-11-18T11:17:07+05:30

Gloom was the predominant mood on the sunny day this aut­umn when Medecins Sans Frontieres (MSF) explained to Delhi journalists how it lost a long legal battle with Pfizer over the pneumococcal conjugate vaccine, or PCV. The US pharma major had been granted a patent for Prevnar 13, said Leena Menghaney, South Asia head of MSF’s Access Campaign. That meant a 68 per cent rise in the cost of the vacc­ine available to developing countries.

The Indian patent authorities’ decision means each dose of the vaccine available to parents will cost Rs 3,800. Moreover, the spike in cost of procurement disables even the government to make the PCV available under the Universal Immuni­sation Programme.

Pfizer’s claim on the patent in India was based on assembling together serotypes (or different strains) of streptococcus pneumonia into a single carrier. The 1849-founded company already held the patent for a 7-valent PCV which also, acc­ording to MSF, an international huma­ni­tarian NGO, denoted a mere addition of serotypes to a vaccine...

Advertisement

Outlook Newsletters

Advertisement
Advertisement
Advertisement

Read More from Outlook

PM Modi Hails India For Creating History With 100 Crore Vaccinations in 279 Days

PM Modi Hails India For Creating History With 100 Crore Vaccinations in 279 Days

The country now has a strong 'protective shield' of 100 crore vaccine doses to combat the biggest pandemic in 100 years, PM said in a video address.

Serum Institute Of India Eyes Exports With Enhanced Covid-19 Vaccine Output: Adar Poonawalla

Serum Institute Of India Eyes Exports With Enhanced Covid-19 Vaccine Output: Adar Poonawalla

The company’s CEO Adar Poonawalla said the company would be able to export 20 to 30 million Covid-19 vaccine doses in November this year.

Deepika Padukone, Ranveer Singh Set To Bid For New IPL Team

Deepika Padukone, Ranveer Singh Set To Bid For New IPL Team

Close to 15 companies, including pharma giants, have shown their interest to bid for the two new IPL teams to be named on October 25 in Dubai.

SpiceJet Introduces Special Livery To Mark India's 100 Crore Feat In Covid-19 Vaccination

SpiceJet Introduces Special Livery To Mark India's 100 Crore Feat In Covid-19 Vaccination

SpiceJet Chairman and Managing Director Ajay Singh said the reaching of 100-crore-dose milestone in mere 279 days was testament to the efforts of health workers.

Advertisement